143 related articles for article (PubMed ID: 28637728)
1. Efficacy of long-acting release octreotide for preventing chemotherapy-induced diarrhoea: protocol for a systematic review.
Deng C; Deng B; Jia L; Tan H
BMJ Open; 2017 Jun; 7(6):e014916. PubMed ID: 28637728
[TBL] [Abstract][Full Text] [Related]
2. Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies.
Rosenoff S
Support Care Cancer; 2004 Aug; 12(8):561-70. PubMed ID: 15160318
[TBL] [Abstract][Full Text] [Related]
3. Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy.
Rosenoff SH
Eur J Cancer Care (Engl); 2004 Sep; 13(4):380-3. PubMed ID: 15305907
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase III trial exploring the use of long-acting release octreotide in the prevention of chemotherapy-induced diarrhea in patients with colorectal cancer: the LARCID trial.
Hoff PM; Saragiotto DF; Barrios CH; del Giglio A; Coutinho AK; Andrade AC; Dutra C; Forones NM; Correa M; Portella Mdo S; Passos VQ; Chinen RN; van Eyll B
J Clin Oncol; 2014 Apr; 32(10):1006-11. PubMed ID: 24516038
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
Rosenoff SH; Gabrail NY; Conklin R; Hohneker JA; Berg WJ; Warsi G; Maloney J; Benedetto JJ; Miles EA; Zhu W; Anthony L
J Support Oncol; 2006 Jun; 4(6):289-94. PubMed ID: 16805331
[TBL] [Abstract][Full Text] [Related]
6. Octreotide in chemotherapy induced diarrhoea in colorectal cancer: a review article.
Bhattacharya S; Vijayasekar C; Worlding J; Mathew G
Acta Gastroenterol Belg; 2009; 72(3):289-95. PubMed ID: 19902860
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of acupuncture for chemotherapy-induced leucopoenia: protocol for a systematic review.
Nian J; Sun X; Guo J; Yan C; Wang X; Yang G; Yang L; Yu M; Zhang G
BMJ Open; 2016 May; 6(5):e010787. PubMed ID: 27231002
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of probiotic in preventing and treating antibiotic-associated diarrhoea and/or Clostridium difficile-associated diarrhoea in patients with spinal cord injury: a protocol of systematic review of randomised controlled trials.
Wong S; Jamous A; O'Driscoll J; Sekhar R; Saif M; O'Driscoll S; Lewis S; McKeown E; Hirani SP
Syst Rev; 2015 Nov; 4():170. PubMed ID: 26596269
[TBL] [Abstract][Full Text] [Related]
9. Thread embedding acupuncture for musculoskeletal pain: a systematic review and meta-analysis protocol.
Cho Y; Lee S; Kim J; Kang JW; Lee JD
BMJ Open; 2018 Jan; 8(1):e015461. PubMed ID: 29374657
[TBL] [Abstract][Full Text] [Related]
10. Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacy.
Wasserman E; Hidalgo M; Hornedo J; Cortés-Funes H
Bone Marrow Transplant; 1997 Nov; 20(9):711-4. PubMed ID: 9384471
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of ginkgo preparations for attention deficit hyperactivity disorder: a systematic review protocol.
He S; Wang M; Si J; Zhang T; Cui H; Gao X
BMJ Open; 2018 Feb; 8(2):e020434. PubMed ID: 29463592
[TBL] [Abstract][Full Text] [Related]
12. Role of octreotide in post chemotherapy and/or radiotherapy diarrhea: prophylaxis or therapy?
Sun JX; Yang N
Asia Pac J Clin Oncol; 2014 Jun; 10(2):e108-13. PubMed ID: 23297685
[TBL] [Abstract][Full Text] [Related]
13. Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315.
Zachariah B; Gwede CK; James J; Ajani J; Chin LJ; Donath D; Rosenthal SA; Kane BL; Rotman M; Berk L; Kachnic LA
J Natl Cancer Inst; 2010 Apr; 102(8):547-56. PubMed ID: 20339140
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: a systematic literature review.
Broder MS; Beenhouwer D; Strosberg JR; Neary MP; Cherepanov D
World J Gastroenterol; 2015 Feb; 21(6):1945-55. PubMed ID: 25684964
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping.
Arts J; Caenepeel P; Bisschops R; Dewulf D; Holvoet L; Piessevaux H; Bourgeois S; Sifrim D; Janssens J; Tack J
Clin Gastroenterol Hepatol; 2009 Apr; 7(4):432-7. PubMed ID: 19264574
[TBL] [Abstract][Full Text] [Related]
16. Herbal medicine (Hyeolbuchukeo-tang or Xuefu Zhuyu decoction) for treating primary dysmenorrhoea: protocol for a systematic review of randomised controlled trials.
Jo J; Leem J; Lee JM; Park KS
BMJ Open; 2017 Jun; 7(6):e015056. PubMed ID: 28619773
[TBL] [Abstract][Full Text] [Related]
17. Acupuncture for patients with chronic urticaria: a systematic review protocol.
Yao Q; Ye Y; Liu X; Qin Z; Liu Z
BMJ Open; 2015 Sep; 5(9):e007704. PubMed ID: 26338683
[TBL] [Abstract][Full Text] [Related]
18. Multicentre, open-label, randomised, parallel-group, superiority study to compare the efficacy of octreotide therapy 40 mg monthly versus standard of care in patients with refractory anaemia due to gastrointestinal bleeding from small bowel angiodysplasias: a protocol of the OCEAN trial.
Grooteman KV; van Geenen EJ; Drenth JP
BMJ Open; 2016 Sep; 6(9):e011442. PubMed ID: 27619827
[TBL] [Abstract][Full Text] [Related]
19. Successful use of long-acting octreotide for intractable chronic gastrointestinal bleeding in children.
O'Meara M; Cicalese MP; Bordugo A; Ambrosi A; Hadzic N; Mieli-Vergani G
J Pediatr Gastroenterol Nutr; 2015 Jan; 60(1):48-53. PubMed ID: 25162361
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
